BioSpace News Archive

Xenon Pharmaceuticals to Present at the 13th Annual Wedbush PacGrow Healthcare Conference

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that management will participate in virtual one-on-one investor meetings and a fireside chat presentation at the 13th Annual Wedbush PacGrow (Virtual) Healthcare Conference.

August 8, 2022
·
1 min read
Pharm Country

BTIG to Host Biotechnology Conference on August 8-9, 2022

BTIG announced today that it will hold its annual Biotechnology Conference on Monday, August 8th and Tuesday, August 9, 2022, in New York.

August 8, 2022
·
2 min read
Business

Biora Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update

Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that it will report second quarter ended June 30, 2022 financial results on Monday, August 15, 2022 after the close of financial markets.

August 8, 2022
·
3 min read
Drug Development

Ondine Biomedical completes patient recruitment for US Phase II nasal photodisinfection trial

Ondine Biomedical Inc. (LON: OBI), has recruited the final patient to its nasal photodisinfection exploratory Phase 2 trial.

August 8, 2022
·
2 min read
Business

Inhibikase Therapeutics to Report Second Quarter 2022 Financial Results on August 12, 2022

Inhibikase Therapeutics, Inc. today announced that it will report financial results for the second quarter ended June 30, 2022 on Friday, August 12, 2022, after the market closes.

August 8, 2022
·
2 min read
Business

Ginkgo Bioworks Announces Date of Second Quarter 2022 Results Presentation

Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2022, on Monday, August 15, 2022, beginning at 4:30 p.m. ET.

August 8, 2022
·
1 min read